Stefano Partelli Selected Research

Stefano Partelli Research Topics

Disease

56	Neoplasms (Cancer) 09/2023 - 07/2007
22	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2024 - 01/2016
20	Pancreatic Fistula (Pancreatic Fistulas) 12/2023 - 07/2007
19	Neoplasm Metastasis (Metastasis) 05/2024 - 02/2012
19	Adenocarcinoma 12/2023 - 09/2012
10	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 02/2012
4	Pancreatitis 12/2023 - 01/2012
4	Margins of Excision 12/2023 - 01/2011
4	Insulinoma 10/2023 - 03/2012
4	Fistula 01/2023 - 06/2019
3	Neoplasms, Cystic, Mucinous, and Serous 05/2022 - 02/2010
3	Hemorrhage 10/2021 - 01/2011
3	Multiple Endocrine Neoplasia Type 1 01/2016 - 03/2012
3	Lymphatic Metastasis 12/2013 - 12/2011
2	Jaundice (Icterus) 12/2023 - 01/2020
2	Fatty Liver 10/2022 - 10/2022
2	Disease Progression 01/2022 - 01/2019
2	Immunoglobulin G4-Related Disease 05/2019 - 10/2018
2	Carcinoma (Carcinomatosis) 07/2015 - 01/2010
2	Hypertrophy 03/2014 - 09/2012
1	Cholangitis 12/2023
1	Fibrosis (Cirrhosis) 12/2023
1	Hyperamylasemia 12/2023
1	Exocrine Pancreatic Insufficiency 01/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Surgical Wound Infection 12/2022
1	Rare Diseases (Rare Disease) 10/2022
1	Cysts 10/2022
1	Thalassemia 10/2022
1	Intellectual Disability (Idiocy) 10/2022
1	Neuroendocrine Carcinoma 06/2022
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 06/2022
1	Anemia 01/2022
1	Inflammation (Inflammations) 01/2022
1	Anastomotic Leak 12/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021
1	Pain (Aches) 01/2020

Drug/Important Bio-Agent (IBA)

4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2022 - 02/2016
4	Peptide Receptors (Peptide Receptor)IBA 01/2022 - 12/2016
4	Radioisotopes (Radionuclides)IBA 01/2022 - 12/2016
4	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 01/2018
4	Everolimus FDA Link 01/2021 - 11/2016
3	Edotreotide (SMT 487)IBA 05/2024 - 09/2020
3	Ga(III)-DOTATOCIBA 01/2023 - 09/2020
3	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2023 - 01/2017
3	Amylases FDA Link 01/2022 - 10/2014
3	C-Reactive ProteinIBA 01/2022 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 05/2019 - 10/2018
2	Octreotide (Sandostatin)FDA LinkGeneric 10/2021 - 01/2021
2	MTOR InhibitorsIBA 01/2021 - 11/2016
2	GlucocorticoidsIBA 05/2019 - 10/2018
2	Serotonin (5 Hydroxytryptamine)IBA 01/2019 - 10/2018
2	Sunitinib (Sutent)FDA Link 01/2019 - 03/2018
1	N- (3- phenyl- n- propyl)- 1- phenyl- 2- aminopropane (PPAP)IBA 12/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 07/2023
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2023
1	Fluorescent Dyes (Fluorescent Probes)IBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	erucylphosphocholineIBA 01/2023
1	Insulin (Novolin)FDA Link 01/2023
1	GalliumIBA 11/2022
1	Proteins (Proteins, Gene)FDA Link 10/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2022
1	Adenosine Monophosphate (AMP)IBA 06/2022
1	A 7 (A-7)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Messenger RNA (mRNA)IBA 11/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	somatostatin receptor 2IBA 06/2020
1	PlatinumIBA 05/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	SmokeIBA 01/2020

Therapy/Procedure

27	Pancreatectomy 09/2023 - 07/2007
26	Pancreaticoduodenectomy 03/2024 - 02/2013
17	Therapeutics 01/2023 - 12/2011
11	Neoadjuvant Therapy 07/2023 - 02/2012
7	Drug Therapy (Chemotherapy) 12/2023 - 02/2016
6	Length of Stay 01/2023 - 07/2007
5	Conservative Treatment 01/2021 - 01/2016
5	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 02/2013
3	Radiofrequency Ablation 10/2023 - 07/2022
3	Liver Transplantation 01/2023 - 10/2014
3	Adjuvant Chemotherapy 12/2021 - 01/2019
2	Stents 12/2023 - 12/2022
2	Blood Transfusion (Blood Transfusions) 01/2022 - 01/2019
2	Aftercare (After-Treatment) 01/2022 - 03/2012
2	Combined Modality Therapy 03/2017 - 02/2016
2	Hepatectomy 03/2014 - 09/2012
2	Operative Surgical Procedures 01/2014 - 03/2012
1	Autologous Transplantation 01/2023
1	Glycemic Control 01/2023
1	Esophagectomy 12/2021
1	Minimally Invasive Surgical Procedures 01/2021
1	Pancreaticojejunostomy 01/2021
1	Appendectomy 12/2020